2 Value Stocks for Long-Term Investors and 1 We Avoid

Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.

Identifying genuine bargains from value traps is something many investors struggle with, which is why we started StockStory - to help you find the best companies. Keeping that in mind, here are two value stocks offering compelling risk-reward profiles and one with little support.

One Value Stock to Sell:

Yelp (YELP)

Forward EV/EBITDA Ratio: 4.9x

Founded by PayPal alumni Jeremy Stoppelman and Russel Simmons, Yelp (NYSE:YELP) is an online platform that helps people discover local businesses through crowd-sourced reviews.

Why Are We Wary of YELP?

1. 6.1% annual revenue growth over the last three years was slower than its consumer internet peers
2. Sales are projected to remain flat over the next 12 months as demand decelerates from its three-year trend
3. Excessive marketing spend signals little organic demand and traction for its platform

Yelp is trading at $25.56 per share, or 4.9x forward EV/EBITDA. Dive into our free research report to see why there are better opportunities than YELP.

Two Value Stocks to Watch:

Workiva (WK)

Forward P/S Ratio: 2.8x

Nicknamed "the Excel killer" by some finance professionals for its ability to eliminate spreadsheet chaos, Workiva (NYSE:WK) provides a cloud-based platform that enables organizations to streamline financial reporting, ESG, and compliance processes with connected data and automation.

Why Does WK Stand Out?

1. Customers view its software as mission-critical to their operations as its ARR has averaged 22.1% growth over the last year
2. Software is difficult to replicate at scale and results in a top-tier gross margin of 79.4%
3. Fast payback periods on sales and marketing expenses allow the company to invest heavily and onboard many customers concurrently

Workiva’s stock price of $52.32 implies a valuation ratio of 2.8x forward price-to-sales. Is now the time to initiate a position? Find out in our full research report, it’s free.

ANI Pharmaceuticals (ANIP)

Forward P/E Ratio: 9.2x

With a diverse portfolio of 116 pharmaceutical products and a growing rare disease platform, ANI Pharmaceuticals (NASDAQ:ANIP) develops, manufactures, and markets branded and generic prescription pharmaceuticals, with a focus on rare disease treatments.

Why Do We Like ANIP?

1. Impressive 33.6% annual revenue growth over the last two years indicates it’s winning market share this cycle
2. Free cash flow margin increased by 38.4 percentage points over the last five years, giving the company more capital to invest or return to shareholders
3. Improving returns on capital suggest its past investments are beginning to deliver value

At $83.79 per share, ANI Pharmaceuticals trades at 9.2x forward P/E. Is now a good time to buy? See for yourself in our full research report, it’s free.

High-Quality Stocks for All Market Conditions

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.